Skip to Content


Office of the Director, Office of Science Policy, Office of Biotechnology Activities; Notice of Meeting

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the meeting of the National Science Advisory Board for Biosecurity (NSABB).

Name of Committee: National Science Advisory Board for Biosecurity.

Date: November 4, 2016.

Time: 12:00 p.m.-3:00 p.m. Eastern.

Agenda: Presentations and discussions regarding: (1) Stakeholder engagement on implementation of the U.S. Government Policy for Institutional Oversight of Life Sciences Dual Use Research of Concern (DURC); (2) status of the Blue Ribbon Panel review of the 2014 variola virus incident on the NIH Bethesda campus; and (3) other business of the Board.

Place: National Institutes of Health, 6705 Rockledge Drive, Suite 750, Bethesda, MD 20892 (Telephone Conference call only; No in-person meeting).

Call-in Information: U.S. Toll-Free Dial-In: 1 (888) 939-3921. Confirmation Number: 43519965.

Contact Person: Christopher Viggiani, Ph.D., Executive Director, NSABB, NIH Office of Science Policy, 6705 Rockledge Drive, Suite 750, Bethesda, Maryland 20892, (301) 496-9838,

Under authority 42 U.S.C. 217a, Section 222 of the Public Health Service Act, as amended, the Department of Health and Human Services established the National Science Advisory Board for Biosecurity (NSABB) to provide advice regarding federal oversight of dual use research—defined as legitimate biological research that generates information and technologies that could be misused to pose a biological threat to public health and/or national security.

The toll-free teleconference line will be open to the public at 11:30 a.m. to allow time for operator-assisted check-in. Persons planning to participate in the teleconference may also pre-register online via the link provided below or by calling Palladian Partners, Inc. (Contact: Ida Donner at 301-273-2838). Pre-registration will close at 12:00 p.m. Eastern on November 1, 2016. After that time, attendees may register their information with the teleconference operator upon dialing into the meeting. Individuals who plan to participate and need special assistance should submit a request to the contact person listed on this notice by October 28.

Meeting materials: The meeting agenda and links to the online pre-registration will be available at:​office-biotechnology-activities/​biosecurity/​nsabb/​nsabb-meetings-and-conferences. Please check this Web site for updates.

Public Comments: Time will be allotted on the agenda for the delivery of oral public comments. Members of the public interested in delivering prepared comments relevant to the mission of the NSABB should indicate so upon registration. Sign-up for delivering prepared oral comments will be limited to one per person or organization representative per open comment period. Individual comments will be time-limited to facilitate broad participation from multiple speakers.

In addition, interested persons may file written comments at any time with the Board via an email sent to or by regular mail sent to the Contact Person listed on this notice. Written statements should include the name, contact information, and when applicable, the professional affiliation of the interested person. Written comments received by 12:00 p.m. Eastern on November 1, 2016 will be relayed to the NSABB prior to the teleconference meeting. Any written comments received after this deadline will be provided to the Board either before or after the meeting, depending on the volume of comments received and the time required to process them in accordance with privacy regulations and other applicable federal policies.

Start Signature

Dated: October 4, 2016.

David Clary,

Program Analyst, Office of Federal Advisory Committee Policy.

End Signature End Preamble

[FR Doc. 2016-24412 Filed 10-7-16; 8:45 am]